The Flow Cytometry Unit is an interdepartmental resource of the Kaplan Comprehensive Cancer Center at the NYU Medical Center whose objective is to make available state-of-the-art flow technology service and training to the members of the Cancer Center. These services are designed to facilitate the research of the members, educate them about the technological possibilities offered by flow techniques and training pre- and post-doctoral students in the use of this technology. The facility operates three instruments: a Coulter EPICS Elite, a Becton Dickinson FACStar Plus and a Becton Dickinson FACScan. These are housed in new quarters on the 3rd floor of the Skirball Institute. The Flow Cytometry ore Laboratory provides sensitive multi-parameter cell marker analysis; quantitative studies of DNA content; kinetic measurements of intracellular Calcium and pH; measurement of membrane fluidity as well as quantitation of the interactions of particles coated with cell adhesion molecules. Analytical quality control is maintained by daily standardization of the instruments with reference beads and by the routine inclusion of reference samples. The laboratory also provides cell-sorting capabilities. Sample preparation is the responsibility of the users of the facility. Cell selection can be performed on up to five parameters at rates exceeding 7,000 cells/second. A single cell deposition device (AutoClone) is available that maintains sterility and permits the instrument to be used for cloning cells. All members of the Center have access to the facility on a first come, first served basis. Cancer Center members have priority over non members have priority over non members. The facility is supported by a combination of user fees, institutional support and the Cancer Center Core Grant.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016087-22
Application #
6315258
Study Section
Project Start
2000-05-19
Project End
2002-11-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
22
Fiscal Year
2000
Total Cost
$268,496
Indirect Cost
Name
New York University
Department
Type
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10016
Xu, Yang; Taylor, Paul; Andrade, Joshua et al. (2018) Pathologic Oxidation of PTPN12 Underlies ABL1 Phosphorylation in Hereditary Leiomyomatosis and Renal Cell Carcinoma. Cancer Res 78:6539-6548
Gagner, Jean-Pierre; Zagzag, David (2018) Probing Glioblastoma Tissue Heterogeneity with Laser Capture Microdissection. Methods Mol Biol 1741:209-220
Tsay, Jun-Chieh J; Wu, Benjamin G; Badri, Michelle H et al. (2018) Airway Microbiota Is Associated with Upregulation of the PI3K Pathway in Lung Cancer. Am J Respir Crit Care Med 198:1188-1198
Martin, Patricia K; Marchiando, Amanda; Xu, Ruliang et al. (2018) Autophagy proteins suppress protective type I interferon signalling in response to the murine gut microbiota. Nat Microbiol 3:1131-1141
de la Parra, Columba; Ernlund, Amanda; Alard, Amandine et al. (2018) A widespread alternate form of cap-dependent mRNA translation initiation. Nat Commun 9:3068
Coux, Rémi-Xavier; Teixeira, Felipe Karam; Lehmann, Ruth (2018) L(3)mbt and the LINT complex safeguard cellular identity in the Drosophila ovary. Development 145:
Patibandla, Jay R; Fehniger, Julia E; Levine, Douglas A et al. (2018) Small cell cancers of the female genital tract: Molecular and clinical aspects. Gynecol Oncol 149:420-427
Fanok, Melania H; Sun, Amy; Fogli, Laura K et al. (2018) Role of Dysregulated Cytokine Signaling and Bacterial Triggers in the Pathogenesis of Cutaneous T-Cell Lymphoma. J Invest Dermatol 138:1116-1125
Harper, Lamia; Balasubramanian, Divya; Ohneck, Elizabeth A et al. (2018) Staphylococcus aureus Responds to the Central Metabolite Pyruvate To Regulate Virulence. MBio 9:
Berger, Ashton C; Korkut, Anil; Kanchi, Rupa S et al. (2018) A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers. Cancer Cell 33:690-705.e9

Showing the most recent 10 out of 1170 publications